Clinical Trial Results Applied to Management of the Individual Cancer Patient

Jatoi, Ismail; Proschan, Michael A.
July 2006
World Journal of Surgery;Jul2006, Vol. 30 Issue 7, p1184
Academic Journal
The application of clinical trial results to the management of the individual cancer patient is not always straightforward. The results of a clinical trial indicate the “average” effect of an intervention, often expressed in terms of an absolute risk reduction, which is an estimate of the likelihood of benefit for a particular patient. However, within any clinical trial, there might be differences between groups of patients in underlying pathology, genetics, or biology, and some patients might benefit more from a new treatment than others. Thus, within a clinical trial, it might also be useful to group together patients with similar characteristics, and test for subgroup interaction. The test for interaction will indicate whether the magnitude of benefit differs from one prognostic subgroup to the next (a quantitative interaction). Much less common are qualitative interactions, in which a new treatment is beneficial in one subgroup but harmful in another. If the test for subgroup interaction is significant, then the effects of treatment may indeed differ between subgroups of patients, but this should be confirmed in other trials before a treatment is implemented in clinical practice.


Related Articles

  • Clinical Trials in Surgical Oncology–Introduction. Jatoi, Ismail // World Journal of Surgery;Jul2006, Vol. 30 Issue 7, p1137 

    The article reports on the importance of clinical trials in managing cancer and cancer patients. Clinical trials as well as patient participation in trials conducted, has contributed in stabilizing mortality rates of cancer patients and has brought improvement in managing the disease....

  • Efficacy of NiTi Hand CACâ„¢ 30 for jejunojejunostomy in gastric cancer surgery: results from a multicenter prospective randomized trial. Hoon Hur; Hyung Ho Kim; Woo Jin Hyung; Gyu Seok Cho; Wook Kim; Seung Wan Ryo; Sang-Uk Han // Gastric Cancer;Jun2011, Vol. 14 Issue 2, p124 

    Background: Although a novel technique for the performance of intestinal sutureless anastomosis using a compression device has recently been investigated, it has not yet received widespread acceptance. We performed a multicenter prospective randomized trial in order to determine the clinical...

  • Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. Crott, Ralph; Briggs, Andrew // European Journal of Health Economics;Aug2010, Vol. 11 Issue 4, p427 

    Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized clinical trials or other prospective non-randomized clinical studies, it is rare that preference-based instruments are used that allow the calculation of a utility weight suitable for estimating...

  • Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities. Murthy, Vivek H.; Krumholz, Harlan M.; Gross, Cary P. // JAMA: Journal of the American Medical Association;6/9/2004, Vol. 291 Issue 22, p2720 

    Context Despite the importance of diversity of cancer trial participants with regard to race, ethnicity, age, and sex, there is little recent information about the representation of these groups in clinical trials. Objective To characterize the representation of racial and ethnic minorities, the...

  • Impact of Cultural and Linguistic Factors on Symptom Reporting by Patients With Cancer. Wang, Xin Shelley; Cleeland, Charles S.; Mendoza, Tito R.; Young Ho Yun; Ying Wang; Okuyama, Toru; Johnson, Valen E. // JNCI: Journal of the National Cancer Institute;5/19/2010, Vol. 102 Issue 10, p732 

    Background: Patient reporting of the severity and impact of symptoms is an essential component of cancer symptom management and cancer treatment clinical trials. In multinational clinical trials, cultural and linguistic variations in patient-reported outcomes instruments could confound the...

  • The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial. Colin Newman; Gregory Pond // Supportive Care in Cancer;Jul2007, Vol. 15 Issue 7, p829 

    Abstract Goals of work  The quality of informed consent in phase I trials is controversial, partially due to gaps in patient understanding. We assessed an educational DVD’s impact on knowledge and satisfaction in cancer patients newly referred to a phase I clinic. Materials and...

  • Access to Drugs for Cancer: Does Where You Live Matter? Menon, Devidas; Stafmnski, Tania; Stuart, Gavin // Canadian Journal of Public Health;Nov/Dec2005, Vol. 96 Issue 6, p454 

    Background: Provincial governments are responsible for administering publicly-funded anti-cancer drug benefit programs in Canada. This study examines inter-provincial variations in not only the content of such programs, but also the policies/processes used when considering a new drug for...

  • A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials. Goffin, John R.; Pond, Greg R.; Tu, Dongsheng // BMC Medical Research Methodology;2011, Vol. 11 Issue 1, p95 

    Background: Response rate (RR) alone may be insensitive to drug activity in phase II trials. Early progressive disease (EPD) could improve sensitivity as well as increase stage I stopping rates. This study compares the previously developed dual endpoint stopping rule (DESR), which incorporates...

  • Dietary Fat Reduction and Breast Cancer Outcome: Interim Efficacy Results From the Women's Intervention Nutrition Study. Chlebowski, Rowan T.; Blackburn, George L.; Thomson, Cynthia A.; Nixon, Daniel W.; Shapiro, Alice; Hoy, M. Katherine; Goodman, Marc T.; Giuliano, Armando E.; Karanja, Njeri; McAndrew, Philomena; Hudis, Clifford; Butler, John; Merkel, Douglas; Kristal, Alan; Caan, Bette; Michaelson, Richard; Vinciguerra, Vincent; Del Prete, Salvatore; Winkler, Marion; Hall, Rayna // JNCI: Journal of the National Cancer Institute;12/20/2006, Vol. 98 Issue 24, p1767 

    Background: Preclinical and observational studies suggest a relationship between dietary fat intake and breast cancer, but the association remains controversial. We carried out a randomized, prospective, multicenter clinical trial to test the effect of a dietary intervention designed to reduce...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics